Takeda(TAK)
The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Actoplus met | Metformin, Pioglitazone | 2005-08-29 | 2023-2035 | |
| Actos | Pioglitazone | 1999-07-15 | 2023-2029 | |
| Adcetris | Brentuximab vedotin | 2012-10-25 | ||
| Adderall | Amphetamine, Amphetamine aspartate, Dextroamphetamine, Dextroamphetamine saccharate | 2001-10-11 | 2024-2038 | |
| Advate | Octocog alfa, Albumin free method, Antihemophilic factor (recombinant), plasma | 2004-03-02 | ||
| Agrylin | Anagrelide | 1997-03-14 | ||
| Alofisel | Darvadstrocel | 2018-03-23 | ||
| Alunbrig | Brigatinib | 2017-04-28 | 2029-2035 | |
| Carbatrol | Carbamazepine | 1997-09-30 | 2024-2040 | |
| Ceradon | Cefotiam | 1988-12-30 |
1
2
3
4
5
6
...
8
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||
1
2
3
4
5
6
...
17
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use